Ipsen header image

Ipsen

IPN

Equity

ISIN FR0010259150 / Valor 2348805

Euronext - Euronext Paris (2026-03-27)
EUR 157.70+3.21%

Ipsen
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Ipsen is a France-based, research-driven biopharmaceutical company that develops, manufactures and commercializes specialty-care medicines with a focus on oncology, rare diseases and neuroscience. Its marketed portfolio includes treatments such as Somatuline (lanreotide) for neuroendocrine tumors and acromegaly, Decapeptyl (triptorelin) in endocrine and oncology indications, and Dysport (abobotulinumtoxinA) for certain neurological and aesthetic uses; the group builds its business through internal R&D, acquisitions and licensing partnerships to advance a pipeline of targeted and rare-disease therapies and to support global commercial operations across Europe, North America and Asia.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

49.6%1Y
52.7%3Y
131%5Y

Performance

27.0%1Y
24.0%3Y
27.5%5Y

Volatility

Market cap

15048 M

Market cap (USD)

Daily traded volume (Shares)

126,762

Daily traded volume (Shares)

1 day high/low

110.8 / 109.9

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Biogen Inc
Biogen Inc Biogen Inc Valor: 1720684
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.78%USD 183.84
Beiersdorf AG
Beiersdorf AG Beiersdorf AG Valor: 324660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.56%EUR 74.80
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.56%EUR 26.00
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.95%USD 31.64
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.85%EUR 2.75
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.17%USD 166.38
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.56%USD 510.68
Evotec SE
Evotec SE Evotec SE Valor: 505433
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.60%EUR 4.30
Outset Medical Inc
Outset Medical Inc Outset Medical Inc Valor: 56717137
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%USD 3.56
Cassava Sciences Inc
Cassava Sciences Inc Cassava Sciences Inc Valor: 46983284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.65%USD 1.67